Background: Clinical translation of immunohistochemistry (IHC) biomarkers requires reliable and reproducible cutoffs or thresholds for interpretation of immunostaining. Most IHC biomarker research focuses on the clinical relevance (diagnostic, prognostic, or predictive utility) of cutoffs, with less emphasis on observer agreement using these cutoffs. From the literature, we identified 3 commonly used cutoffs of 10% positive epithelial cells, 20% positive epithelial cells, and moderate to strong staining intensity (+2/+3 hereafter) to use for investigating observer agreement.
T he use of immunohistochemistry (IHC) biomarkers for clinical decision-making is an important research field with significant translational potential. A multitude of biomarkers for a variety of cancers is available, and large literature exists on novel biomarker discovery, but only a minority of them have an impact on patient care. Among other reasons, one barrier to clinical translation of biomarkers is the lack of a standardized cutoff or threshold for interpretation of IHC staining. 1, 2 Evaluation of immunostaining is important in translational studies assessing biomarker expression for diagnostic, prognostic, or predictive purposes. Biomarker expression assessment usually uses a continuous or ordinal scale; however, for meaningful clinical use, it is usually dichotomized and a cutoff is established for assigning a patient into either positive/negative expression category or high/low expression category. 3 In addition, for some biomarkers, more than 2 categories may be required-for example, the "Allred score" for estrogen receptor (ER) positivity. 4 For clinical translation, there are 2 main issues in the development and application of a standardized cutoff for IHC biomarkers. One is the identification of an appropriate cutoff that provides suitable sensitivity/specificity for diagnostic biomarkers or that stratifies patients on the basis of survival and response to treatment for prognostic and predictive biomarkers, respectively. The other issue is to assess the interobserver and intraobserver agreement in the interpretation of a cutoff threshold. One potential strategy to address the former is the use of a receiver operating characteristics curve that can help to identify an appropriate cutoff. 1, 5 The latter issue can be answered by assessing the level of agreement between pathologists. [6] [7] [8] There is currently no standardized cutoff for diagnostic IHC biomarkers. Most of the reported cutoffs are purposive that best fit cancer or normal groups. These cutoffs are based on the intensity of staining or the percentage of positive cells or on a combination of both intensity and percentage in terms of immunoreactive scores, H scores, and "quick" scores. 7, [9] [10] [11] [12] [13] Two widely used cutoffs reported in the literature for IHC diagnostic biomarkers are positive/negative staining (eg, p16/Ki-67 staining for the diagnosis of cervical intraepithelial neoplasia 3) and 10% positive epithelial cells [eg, a panel of napsin A, TTF 1, cytokeratin (CK)5, and p63 in differentiating adenocarcinoma from squamous cell carcinoma of the lung]. [14] [15] [16] [17] [18] [19] Other reported cutoffs are as follows: >30% cells with uniform, intense membranous staining of invasive tumor cells for human epidermal growth factor receptor 2 (HER2) (positive HER2 staining in breast cancer) 20 and >5% positive tumor cells for CK7 and CK20 (differential diagnosis in metastatic carcinoma of unknown origin). 21 These scoring systems and cutoffs have been adopted for research purposes. Some of them are used in clinical practice, but studies looking at their reproducibility between pathologists are few. A cutoff should be both clinically relevant and easily interpretable by pathologists. There is a tendency to focus more on the clinical relevance of the cutoff for a biomarker with less focus on the level of agreement between pathologists when they use it for scoring purposes. 6, 22 Interobserver and intraobserver variation of a cutoff is infrequently analyzed despite the fact that it is recognized as a potential barrier to clinical translation.
We selected 3 cutoffs for investigation based on our diagnostic IHC work 23 and the wider IHC literature. These cutoffs are 10% positive epithelial cells (10% hereafter), 20% positive epithelial cells (20% hereafter), and moderate to strong staining intensity with any proportion of positive cells (+2/+3 hereafter). 8, 14, 17, [23] [24] [25] [26] [27] These cutoffs are clinically relevant, and we postulated that they are easily interpretable and reproducible among pathologists. The aims of the current study were to investigate the cutoffs (10%, 20%, and +2/+3) for interobserver and intraobserver agreement, and to explore factors influencing agreement between pathologists for IHC cutoffs.
MATERIALS AND METHODS

IHC Images and Participants
A series of 36 images of pancreatic ductal adenocarcinoma tissue microarray cores for 4 diagnostic IHC biomarkers (9 images each from KOC, maspin, mesothelin, and S100P) were used for this study. These cores have previously been studied for diagnostic utility. 23 These cores were carefully selected for each biomarker based on a variable range of staining intensity and proportion of positive cells. Some cores with no immunostaining were also included. The purpose of using images from 1 type of tumor, that is, pancreatic ductal adenocarcinoma, was to allow the observers to concentrate on the immunostaining cutoffs rather than interpreting the morphology of different tumors. KOC expression was cytoplasmic; maspin has both cytoplasmic and nuclear expression but the pathologists were asked to score only cytoplasmic staining for maspin and disregard nuclear staining; mesothelin expression was cytoplasmic and/or membranous; and S100P expression was cytoplasmic and/or nuclear. Seven pathologists (3 experienced pathologists and 4 junior pathologists) participated in the study. Experienced pathologists have clinical pathology experience of >15 years, whereas junior pathologists have 3 to 7 years of experience. All pathologists were sufficiently trained to evaluate pancreatic tumors. Pathologists were coded as A, B, C, D, E, F, and G. Ethics approval has been granted by the North Glasgow University Hospitals NHS Trust Ethics Committee and by the National Health Service Greater Glasgow and Clyde Ethics Committee. This ethics approval includes the use of archival pathology specimens, where the patients were not given the opportunity to donate their tissue.
Scoring the IHC Cutoffs
The 36 images were shown by projection on Powerpoint, and were arranged based on biomarkers with reference staining intensities (weak, moderate, severe) provided at the start for each biomarker. A scoring sheet with instructions on scoring was prepared with the help of pathology colleagues (supplementary Table 1 , Supplemental Digital Content 1, http://links.lww.com/AIMM/ A112). All the participating pathologists participated in 1 session for the interobserver part of the study. After a short presentation (5 to 10 min) on the purpose of this study, the scoring sheets were distributed between all 7 pathologists. Each image was shown for 1 minute. The pathologists were asked to interpret the immunostaining of each image for the 3 cutoffs as a binary categorical variable, "present" or "absent." The 3 cutoffs were 10%, 20%, and +2/+3 cutoffs. For example, a 10% cutoff is "present" when Z10% epithelial cells are positive in the desired subcellular compartment and is "absent" when <10% epithelial cells are positive. Each core was also recorded as being easy (1) or challenging (2) to score.
All 7 pathologists participated in the intraobserver part of the study 3 weeks after the interobserver session. The tissue core images shown were the same, but they were arranged in a different order to minimize recall bias.
Statistics and Data Analysis
We used kappa (k) scores as a measure of the strength of agreement between pathologists for all 3 cutoffs. k scores reflect the strength of agreement between observations, adjusted for chance agreement, and can range from 0 to 1. We used the standards suggested by Landis and Koch 28 for the interpretation of strength of agreement. k scores are shown in 6 categories from 0 to 1, and each category is color-coded (supplementary Table 2 , Supplemental Digital Content 2, http://links.lww.com/ AIMM/A113).
Interobserver Agreement
To determine interobserver agreement for each of the 3 cutoffs, each pathologist's interpretation of immunostaining was compared with that of the other pathologists in a pairwise manner. In total, 21 interobserver (AB, AC, AD and so on y) k scores were generated for each of the 3 cutoffs (10%, 20%, and +2/+3). Finally, a mean interobserver k score for each cutoff was used as a measure of strength of agreement between pathologists.
Impact of Pathologists' Experience and Antibody Staining Pattern on Interobserver Agreement
For each cutoff, mean interobserver k scores were calculated for experienced pathologists and for junior pathologists and then compared. The staining pattern was noted for the antibody used in each slide, and mean k scores were calculated for each staining pattern. The aim was to determine whether the pathologists tend to have more agreement for a particular staining pattern (cytoplasmic, nuclear, and/or membranous).
To determine whether these 3 cutoffs are statistically different from each other, the paired sample t test (for large sample size) and Wilcoxon signed ranked test (for small sample size) were used to compare the pairwise k scores. To determine which cutoff is most easily scored, these 3 cutoffs as predictor variables were put in a linear regression model against perceived ease of scoring as a dependent variable.
Intraobserver Agreement
To determine reproducibility of these 3 cutoffs, k scores were generated comparing scoring and rescoring of the same image arranged in different orders 3 weeks apart for each pathologists. k scores were generated for all 7 pathologists (A-A, B-B, C-C, D-D, E-E, F-F, and G-G) using the 3 cutoffs. Seven intraobserver agreements were generated for each cutoff. A mean intraobserver k score for each cutoff was then used as a measure of strength of agreement.
A P-value <0.05 was considered statistically significant. SPSS version 21 was used for statistical analyses.
RESULTS
Taken together, 1512 evaluations were made in the interobserver and intraobserver sessions by the pathologists. The average time for interpretation of an image was roughly 30 to 45 seconds. Results are divided into 3 parts: interobserver agreement; perceived ease of scoring; and intraobserver agreement.
Interobserver Agreement All 7 Pathologists
The mean interobserver k scores were 0.64, 0.59, and 0.62 for 10%, 20%, and +2/+3 cutoffs, respectively ( Table 1 ). The mean k score agreement for 10% and +2/ +3 cutoffs is in the "substantial" agreement category and for the 20% cutoff is in the "moderate" agreement category. However, the k score agreements between the 3 cutoffs were not statistically different from each other (supplementary Fig. 1 , Supplemental Digital Content 3, http://links.lww.com/AIMM/A114). Figure 1 shows examples of IHC images used in this study. Images with low observer agreement have either weak staining intensity or the proportion of positively stained cells is lower compared with images with a high level of agreement. In fact, tissues with both strong staining intensity and a higher percentage of positive cells have higher agreement regardless of the biomarker and staining pattern.
In summary, the interobserver agreements between all 7 pathologists for the 3 cutoffs were reasonably good. In addition, the agreements for the cutoffs were not statistically different from each other.
Impact of Pathologists' Experience on Interobserver Agreement
The mean interobserver k scores for experienced pathologists were 0.81, 0.70, and 0.55 for 10%, 20%, and +2/+3 cutoffs, respectively (Table 2A ). The mean interobserver k scores for junior pathologists were 0.61, 0.60, and 0.73 for 10%, 20%, and +2/+3 cutoffs, respectively (Table 2B ). The agreement on 10% cutoff is statistically higher for the experienced pathologists than for the junior pathologists (P = 0.02, Mann-Whitney U test). However, no statistically significant difference between experienced and junior pathologists was observed for 20% and +2/+3 cutoffs. In summary, a higher level of agreement was observed for experienced pathologists using 10% cutoff, and this was statistically higher than that for junior pathologists. Comparison of pairwise k scores with color codes between pathologists (A-G) in the evaluation of immunohistochemistry using 10%, 20%, and +2/+3 cutoffs are shown with mean k score and 95% CI separately for each cutoff.
CI indicates confidence interval.
Impact of Antibody Staining Pattern on Interobserver Agreement
In the images studied, there were 3 staining patterns: cytoplasmic-only staining; cytoplasmic and/or nuclear staining (CN); and cytoplasmic and/or membranous staining (CM).
The mean k scores for cytoplasmic-only staining were higher than the other staining patterns. More specifically, a statistically higher agreement for cytoplasmiconly staining was observed in the following scenarios: cytoplasmic compared with CN category using +2/+3 cutoff and cytoplasmic compared with CM category using 20% and +2/+3 cutoffs.
Moreover, a statistically higher agreement for CN staining was observed in the following scenarios: CN compared with CM category using 20% and +2/+3 cutoffs. No statistically significant difference between different staining patterns was observed for the 10% cutoff (Table 3) . In summary, there is more interobserver agreement for cytoplasmic-only staining followed by CN and CM. Finally, the 10% cutoff seems to yield good interobserver agreement irrespective of the staining compartment of the cell.
Relationship Between Cutoffs and Perceived Ease of Scoring
A positive correlation was observed between all 3 cutoffs and perceived ease of scoring (P < 0.0001). However, in a multivariate analysis, the 10% cutoff (b = 0.41, P < 0.001) was more easily scored as compared with the +2/+3 cutoff (b = 0.38, P = 0.001) or the 20% cutoff (b = 0.34, P = 0.004) (Table 4) .
Interestingly, the pattern emerging from this correlation that 10% is relatively more easily scored, followed by +2/+3 and 20%, supports the mean interobserver and intraobserver k scores for these cutoffs (Tables 1, 5 ).
Intraobserver Agreements
The mean intraobserver k scores were 0.71, 0.60, and 0.73 for 10%, 20%, and +2/+3 cutoffs, respectively ( Table 5 ). The k score agreement for 10% and +2/+3 cutoffs is in the "substantial" agreement category and for the 20% cutoff it is in the "moderate" agreement category. However, the k score intraobserver agreements between all 7 pathologists for the 3 cutoffs were not statistically different (supplementary Fig. 2 , Supplemental Digital Content 4, http://links.lww.com/AIMM/A115).
In summary, the intraobserver agreements for the 3 cutoffs were reasonably good. In addition, the agreements for the 3 cutoffs were not statistically different from each other. Thus, a good intraobserver agreement confirms the reproducibility of these cutoffs by pathologists, and again this supports their use for IHC biomarkers.
The interobserver and intraobserver agreements follow the same pattern-that is, "substantial" agreement The 10%, 20%, and +2/+3 are predictor variables-that is, they are variables that are predicting an outcome (the ease of interpretation). In this regression model, ease of interpretation is a dependent variable-that is, a variable that "depends" on the predictor variable. The standardized beta coefficients were used as an estimate of association between predictor and dependent variable. The higher the beta coefficient the higher is the P-value significance and the stronger is the association between predictor and dependent variables. Beta coefficient in this model is highest (0.41) for 10% cutoff, followed by +2/+3 (0.38) and 20% (0.34). However, the P-value for all 3 cutoffs is significant showing a positive association with ease of interpretation. Pairwise k scores showing intraobserver reproducibility from scoring and rescoring (eg, A-A) of all 7 pathologists (A-G) in the evaluation of Immunohistochemistry using 10%, 20%, and +2/+3 cutoffs.
for 10% and +2/+3 and "moderate" agreement for 20% cutoffs.
DISCUSSION
Three IHC cutoffs, namely 10%, 20%, and +2/+3, were assessed for observer agreement between pathologists. All cutoffs demonstrated good interobserver and intraobserver agreement between pathologists. Similarly, all 3 cutoffs showed high correlation with perceived ease of scoring. Finally, the observer agreement for cytoplasmic-only staining was higher than CN and CM.
Establishing a cutoff for biomarker assessment is an essential prerequisite for clinical translation. A wide range of cutoffs have been used for diagnostic, prognostic, and predictive IHC biomarkers in research and clinical settings. The purpose of a cutoff for a diagnostic biomarker is to assign patients into positive or negative categories with reasonable sensitivity without compromising specificity. 29 On the basis of the expression level for a candidate biomarker in cancer and normal tissue, a cutoff is established. A good diagnostic cutoff has a low probability of false positivity and false negativity. 29 The purpose of a cutoff for a prognostic biomarker is to divide the population into categories of longer and shorter survival for the outcome. In research settings, a cutoff based on percentage of positive tumor cells is mostly used. 30, 31 Similarly, the aim of a cutoff for predictive biomarkers is to stratify patients into likely responders and nonresponders to treatment and intervention. 32 IHC cutoffs used for prognostic and predictive biomarkers have been investigated for observer agreement, but such studies are limited for diagnostic biomarkers. The cutoffs of 10% and 30% positive cells with strong membranous staining for HER2 have been investigated for reproducibility among pathologists. 8 In addition, for ER and progesterone receptor, the continuous H-score (range, 0 to 300) and categorical scores (negative: Hscore < 1, positive: H-scoreZ1) have been investigated for interobserver agreement. 7 These cutoffs for HER2, progesterone receptor, and ER are clinically important and are used in clinical practice by pathologists.
Clinically relevant cutoffs are important for biomarker evaluation. We sought to investigate 3 cutoffsthat is, 10%, 20%, and +2/+3-with the hope that if evidence of their scoring reproducibility is provided, they could potentially help the clinical translation of IHC biomarkers. Interestingly, the purpose of cutoffs differ for different biomarkers, but these 3 cutoffs have been used for diagnostic [S100P, pVHL, KIT, HMGI(Y), CK20, P53, Ki-67], 14, 17, 24, 26, 27 prognostic (Ki-67, p53), and predictive (APAF-1, EGFR) biomarkers. [33] [34] [35] [36] Therefore, investigating the strength of agreement between pathologists for these 3 cutoffs has significant clinical importance.
Interobserver agreement between pathologists was used to elucidate the reliability of cutoffs. A "substantial" agreement was observed with overall mean k scores of 0.64 and 0.62 for 10% and +2/+3 cutoffs, respectively, whereas "moderate" agreement with a k score of 0.59 was observed for 20% cutoff. In a study comparing the 10% positivity with 30% positivity for HER2, the mean k scores for interobserver agreement were 0.49 for 10% positive cells and 0.54 for 30% positive cells. 8 Clearly, the k scores generated for the 3 cutoffs under investigation in our project are comparable to the k scores for HER2, which is already in clinical practice as a predictive biomarker. Moreover, studies looking at the interobserver reproducibility in histopathology and the IHC literature have shown that k scores >0.60 (substantial agreement) are regarded as a good level of agreement. In comparison, k scores <0.40 (fair agreement) are regarded as an unacceptably low level of agreements for diagnostic purposes. [37] [38] [39] [40] [41] Intraobserver agreement of the scoring and then rescoring of the same image was used to assess reproducibility of the cutoffs. Again a pattern similar to interobserver agreement emerged with "substantial" agreements for the 10% and +2/+3 cutoffs and "moderate" agreement for 20% cutoff. However, the intraobserver agreements (0.71, 0.60, and 0.73) in the present study are higher than interobserver agreements (0.64, 0.59, and 0.62) for the 3 cutoffs. This finding agrees with the previous literature that the intraobserver agreement is more than the interobserver agreement. For example, the intraobserver agreement (k = 0.85) is better than the interobserver agreement (k = 0.80) for PDX-1 IHC staining intensity in prostate cancer. 42 In addition, the intraobserver agreement (k = 0.78) is better than the interobserver agreement (k = 0.65) for evaluation of focal cortical dysplasia categories. 43 Taking 10% positive cells as a cutoff has been used for a variety of IHC biomarkers in different cancer types. These include S100P and XIAP in the differentiation of pancreatic cancer from non-neoplastic pancreatic tissue, and for a panel of napsin A, TTF 1, CK5, and P63 in differentiating adenocarcinoma from squamous cell carcinoma of the lung. 19, 44 Moreover, 10% cutoff is prognostic in breast cancer for a panel of Ki-67 and p53, predictive of event-free survival in stage II colon cancer for VEGF, and is predictive in rectal tumors treated with preoperative, high-dose-rate brachytherapy for APAF-1. 34, 36, 45 The use of a 10% cutoff in other areas of pathology means that the more experienced pathologists in the present study will have already had experience in applying this cutoff, which is a possible explanation for why they have a higher agreement than junior pathologists. Studies have attempted to show that the reproducibility of the 10% cutoff and the k scores achieved in the current study (0.64, substantial agreement) is similar to the k scores (0.57 to 0.77, moderate to substantial) in the reported literature. 34, [46] [47] [48] The 20% positive staining cutoff has also been used for a variety of IHC biomarkers. These include Ki-67 as a prognostic biomarker in breast carcinoma 49 and NF-E2 in the differentiation of essential thrombocythemia from primary myelofibrosis. 50 However, studies investigating the variation in interpretation of this cutoff between pathologists are very limited. The current study investigated the 20% cutoff for observer agreement, and our results suggested a good level of agreement.
Moderate to strong staining intensity and any percentage of positive cells (+2/+3) as a cutoff has also been used for IHC biomarkers. These include CK20, P53, CK5/6, CD138, and Her2/Neu in the diagnosis of urothelial carcinoma in situ and the use of claudin-4 to distinguish adenocarcinoma from malignant mesothelioma in effusion cytology. 26, 51, 52 However, once again, studies observing the variation in interpretation of this cutoff between pathologists are very limited. Our results demonstrate that this cutoff is also reliable, reproducible, and easy to score, and it can be ranked second to the 10% cutoff from the current study.
The observer agreement was also assessed using staining in different cellular compartments. Staining in only the cytoplasmic compartment achieved higher agreements than other staining patterns.
The interpretation of membranous staining for HER2 in breast cancer is used in routine clinical practice. Hameed et al 8 investigated interobserver agreement using 10% positive cells with membranous staining for HER2 in breast cancer. The authors found a mean interobserver agreement k score of 0.49. 8 We also investigated interobserver agreement using 10% positive cells with membranous staining for mesothelin in pancreatic cancer and observed a k score agreement of 0.62. Thus, 10% cutoff and membranous staining achieve reasonable observer agreement not only for HER2 in breast cancer but for other biomarkers in a different cancer and warrants further investigations.
The sample size was good and 7 pathologists participated in the present study. This number is comparable to the IHC biomarker and histopathology literature (4 to 7 participants) in which observer agreement was investigated. 42, [53] [54] [55] In addition, the participants in the current study were practicing pathologists with variable levels of experience as compared with studies in which either physicians (with no formal pathology experience) 42 or researchers with experience in IHC were recruited. 54 Thus, the results of this study provide good evidence on the use of cutoffs for IHC biomarkers.
The limitations include the relatively few number of images because of the time constraints imposed by the clinical work of the pathologists, and all pathologists were from the same institution; the aim was to carry out the study with all of the pathologists present at 1 session and this was achieved for the interobserver part but for the intraobserver part we had to arrange an extra session. An important limitation results from the fact that images were shown as a PowerPoint presentation on screen rather than using a standard microscope.
CONCLUSIONS
In a day-to-day clinical practice, pathologists need scoring systems and cutoffs that are reproducible and easy to use. 1, 8 A wide range of cutoffs have been used for IHC biomarkers. We selected 10%, 20%, and +2/+3 cutoffs that have been used previously in clinical practice. These 3 cutoffs are reliable and reproducible, achieving a reasonably good agreement level between pathologists (when compared with the literature). They could facilitate translational biomarker studies and could potentially be used by scientists who are not trained pathologists but are involved in investigating IHC biomarkers. A biomarker achieving diagnostic, prognostic, and/or predictive significance with any of the 3 cutoffs may have translational potential. Further studies are required to assess these cutoffs with pathologists from different institutions and using a larger sample of images.
